Top Story

FDA clears FFR-CT system for marketing

November 26, 2014

The FDA announced that it has cleared for marketing a software system to compute fractional flow reserve from noninvasive CT angiography.

The FFR-CT system (HeartFlow, HeartFlow Inc.) provides health care professionals noninvasive evaluation of blood flow in the coronary arteries of patients with signs or symptoms of CAD, according to an FDA press release. The agency reviewed the system via the de novo premarket review pathway, which is for low-to-moderate-risk devices that are not substantially equivalent to an existing device.

Meeting News Coverage

WOSCOPS: 20-year follow-up demonstrates clinical benefit of statins in men

November 26, 2014
CHICAGO — At 20 years, men assigned statin therapy during the 5-year West of Scotland Coronary Prevention Study had lower rates for mortality and CV events…
Doug Mann Meeting News Coverage

AUGMENT-HF: Novel implantable device safe, effective in patients with advanced HF

November 26, 2014
CHICAGO — A novel implantable device was administered safely and associated with clinical benefit in patients with advanced HF, according to phase 2 trial data…
thumbnail for video 3909640743001 Meeting News CoverageVideo

VIDEO: Increased infective endocarditis incidence in England may merit re-evaluation of treatment guidelines

November 25, 2014
CHICAGO — In this video, John G. Harold, MD, cardiologist at the Cedars-Sinai Heart Institute, discusses data presented at the American Heart Association…
In the Journals

PROTECTION AMI: Cardiac troponin I levels predicted STEMI outcomes

November 25, 2014
In a new analysis, researchers reported an independent association between measurement of cardiac troponin I levels after primary PCI for STEMI and clinical outcomes and…
More News Headlines »
CME
Managing Acute Ischemic Stroke in the Emergency Department: Two Decades of Progress

Managing Acute Ischemic Stroke in the Emergency Department: Two Decades of Progress

This activity is supported by an educational grant from Genentech.

According to the American Heart Association Heart Disease and Stroke Statistics 2013 Update, approximately 795,000…
More »
Meeting News Coverage Video
thumbnail for video 3907832195001

Anna Axelsson, MD: Results from INHERIT do not 'close the door' on losartan

November 24, 2014
CHICAGO — While results from the INHERIT trial indicate that losartan had no effect on left ventricular mass or…
More »
CME
Challenges and Opportunities in the Treatment of Acute Ischemic Stroke: Key Points for the Emergency Physician

Challenges and Opportunities in the Treatment of Acute Ischemic Stroke

This activity is supported by an educational grant from Genentech.

According to the American Heart Association Heart Disease and Stroke Statistics – 2013 Update, approximately 795,000…
More »
morganatic-roan